Partial list from a bibliography of 1 13 publications: 
1. Sobol RE, Burton D, Schaeffer MT, Tice D, Royston I, Deftos LJ: Unique subset of Thymic 
epithelial cells defined by the expression of a novel neuroendocrine antigen. CELL IMMUNOL 
A115(l):121-129, 1988. 
2. Davey FR, Mick R, Nelson DA, MacCallum J, Sobol RE, Royston I, Cuttner J, Ellison RR, and 
Bloomfield CD: Morphologic and cytochemical characterization of adult lymphoid leukemias which 
express myeloid antigen. LEUKEMIA, 2(7):420-426, 1988. 
3. Skaletsky E, OH E, Rulot C, Baird SM, Burnett KG, Masuho Y, Astarita RW, Haghighi P, Wolf P, 
Collins H, Starr R, Carlo DJ, Royston I and Sobol RE: A human monoclonal antibody to cytokeratin 
intermediate filament antigens derived from a tumor draining lymph node. HYBRIDOMA, 7(4):367- 
376, 1988. 
4. Boemer P, and Royston I: Production of human monoclonal antibodies by in vitro immunization. 
Human Tumor Antigens and Specific Tumor Therapy, UCLA Symposia on Molecular and Cellular 
Biology, New Series, Vol 99, eds, R. Metzgar & M. Mitchell, New York, pp 147-156, 1989. 
5. Miller RA, Hart S, Samoszuk M, Coulter C, Kelkenberg BS, Brown S, Royston I and Levy R: 
Shared idiotopes expressed by human B cell lymphomas. NEW ENGLAND JOURNAL OF 
MEDICINE, 321:851-857, 1989. 
6. Parker BA, Vassos A, Halpem SE, Miller R, Hupf H, Amox D, Green MR, Royston I: ^oyttrium 
anti-idiotype therapy of non-Hodgkin's lymphoma. CANCER RES (suppl.) 50:1022-1028, 1990. 
7. Parker BA, Halpem SE, and Royston I: Radioimmunotherapy with ^oyttrium-anti-idiotype 
monoclonal antibc^y. Therapeutic Monoclonal Antibodies, eds. Carl Borrebaeck and James Larrick, 
Stockton Press, 1990, pp 127-142. 
8. Swisher EM, Shawler DL, Collins HA, Bustfia A, Hart S, Bloomfield C, Miller RA and Royston I: 
The expression of shared idiotypes in chronic lymphocytic leukemia and small lymphocytic 
lymphoma. BLOOD, 77: 1977-1982, 1991. 
9. Boemer P, LaFond R, Lu EW, Brams P, Royston, I: Production of antigen-specific human 
monoclonal antibodies from in vitro primed human lymphocytes. J. IMMUNOL I47(I):86-95, 1991. 
10. Ellison RR, Mick R, Cuttner J, Schiffer C, Silver R, Henderson ES, Green MR, Royston I, Davey 
FR, Glicksman AS, and Holland JF: The effects of post-induction intensification treatment with 
cytokine arabinoside and daunorubicin in acute lymphocytic leukemia of adults: A prospective 
randomized clinical trial by Cancer and Leukemia Group B. J CLIN ONCOL 9:2002-2015, 1991. 
11. Kohler H, Okuda Y, Chen JJ, Parker BA, and Royston I: Immunotherapy of B cell malignancy with 
anti-shared idiotype antibodies does not suppress idiotype producing normal B cells. HYBRIDOMA, 
1992. 
12. Parker BA, Halpem SE, Miller RA, Hupf HB, Shawler DL, Collins HA, Amox DA, White CA, and 
Royston I: Radioimmunotherapy of relapsed B cell lymphoma with ^Yttrium anti-idiotype 
monoclonal antibodies. NEJM, (submitted). 
13. Brams P, Royston I. and Boemer, P: In vitro Immunization of Human Lymphocytes: I. IL-2 and IL- 
4 requirements. HUMAN ANTIBODIES AND HYBRIDOMAS, 1992. 
14. Brams P, Royston 1, and Boemer P: In vitro Priming of Human Lymphocytes: II. Induction of 
antigen specific IgG responses by repeated antigen stimulation. HUMAN ANTIBODIES AND 
HYBRIDOMAS, 1992. 
15. Newman RA, Brabyn C, Collins H, Royston 1: Phenotypic markers and BCL-1 gene rearrangements 
in B cell chronic lymphocytic leukemia: A cancer and leukemia group B study. Blood, 1992. 
16. Boemer P, Brams P, Royston 1: In vitro Immunization of Human Lymphocytes: Induction of 
specific, primary responses to high molecular weight protein antigens. J IMMUNOL METHODS, 
(submitted). 
17. Brams P, Royston I, and Boemer P: In vitro Immunization of Human Lymphocytes: Further 
characterization of mixed splenocyte culture immunization. J IMMUNOL METHODS, (submitted). 
18. Kohler H, Okuda Y, Chen JJ, and Royston I: Immunotherapy of a B cell lymphoma patient with anti- 
shared idiotope antibodies does not suppress normal idiotype production. Vaccine Research, 1993. 
19. Lu EW, Bustria AT, Royston I, and Brams P: Factors affecting production of antibodies to prostate 
antigens by in vitro -primed human splenocytes. HYBRIDOMA, 1993. 
20. Newman, RA, Peterson B, Davey FR, Brabyn C, Collins HA, Brunetto VL, Duggan DB, Weiss RB, 
Royston I, Millard FE, Miller AA, Bloomfield CD: Phenotypic Markers and BCL-1 Gene 
Rearrangements in B-Cell Chronic Lymphocytic Leukemia: A Cancer and Leukemia Group B Study. 
Blood, 82: 1239-1246, 1993. 
Recombinant DNA Research, Volume 19 
642 ] 
